Holen Sie sich die Stockscreener-App
194.51
1.52%
-3.00
Schlusskurs vom Vortag:
$197.51
Offen:
$197.75
24-Stunden-Volumen:
463.87K
Relative Volume:
1.35
Marktkapitalisierung:
$5.63B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
65.05
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
+2.41%
1M Leistung:
+6.08%
6M Leistung:
+17.06%
1J Leistung:
+10.27%
1-Tages-Spanne:
$184.02
$198.98
1-Wochen-Bereich:
$183.26
$198.98
52-Wochen-Spanne:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
194.45 | 5.72B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.14 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
643.35 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.69 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.16 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration - MSN
Krystal Biotech Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Transcript : Krystal Biotech, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Is Krystal Biotech Inc. stock gaining market shareJuly 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
What macro factors could drive Krystal Biotech Inc. (4KB) stock higher2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript - The Globe and Mail
Earnings call transcript: Krystal Biotech Q3 2025 beats EPS forecasts, shares dip - Investing.com
Will Krystal Biotech Inc. see short term momentumMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Krystal Biotech’s Profits Rose As Vyjuvek Reached New Markets - Finimize
Tick level data insight on Krystal Biotech Inc. volatilityDip Buying & Free Weekly Watchlist of Top Performers - newser.com
Krystal Biotech (KRYS) Projects Significant Expenses for FY25 - GuruFocus
Krystal Biotech Inc Surpasses Q3 Estimates with $2.74 EPS and $97.8 Million Revenue - GuruFocus
Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95 - MarketScreener
Earnings Flash (KRYS) Krystal Biotech, Inc. Reports Q3 Revenue $97.8M, vs. FactSet Est of $93.2M - MarketScreener
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results - The Manila Times
Krystal Biotech, Inc. SEC 10-Q Report - TradingView
Krystal Biotech Q3 net income triples - TradingView
Will Krystal Biotech Inc. (4KB) stock issue positive guidanceJuly 2025 WrapUp & Long-Term Safe Return Strategies - newser.com
Will breakout in Krystal Biotech Inc. lead to full recovery2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
How Krystal Biotech Inc. (4KB) stock trades under stagflation2025 Winners & Losers & Fast Entry High Yield Tips - newser.com
Torray Investment Partners LLC Makes New $1.59 Million Investment in Krystal Biotech, Inc. $KRYS - MarketBeat
Analyzing Krystal Biotech Inc. with multi timeframe chartsJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
How to integrate Krystal Biotech Inc. into portfolio analysis toolsTrade Risk Assessment & Daily Entry Point Trade Alerts - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streamsJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Why Krystal Biotech Inc. stock is recommended by analystsShare Buyback & Stock Portfolio Risk Management - newser.com
Institutional scanner results for Krystal Biotech Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Krystal Biotech Inc. stock a safe buy before earningsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Should you hold or exit Krystal Biotech Inc. nowMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-02 02:39:07 - newser.com
Is Krystal Biotech Inc. stock safe for conservative investorsJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Why retail investors favor Krystal Biotech Inc. stockJuly 2025 Recap & Verified Chart Pattern Trade Signals - newser.com
Is it time to cut losses on Krystal Biotech Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Krystal Biotech Inc. stock ready for a breakoutQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):